Ugur Sahin and Özlem Türeci were instrumental in developing the first COVID-19 vaccine to be approved in the West. Now they say they "are ready to become pioneers once again." ...
BioNTech's co-founders, Ugur Sahin and Oezlem Tuereci, plan to leave by year's end to start a new venture, causing BioNTech's shares to plummet. The couple aims to focus on mRNA-based drugs at an ...
Wall Street is adjusting to a historic spike and fall in oil prices after the global economy was thrown into disarray.
BioNTech shares are crashing as the company posted a disappointing Q4 release and announced cofounders departure by the end of 2026. Here’s why BNTX stock is still worth buying today.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results